Published in Clin Infect Dis on July 01, 2012
Seasonal variation in penicillin use in Mexico and Brazil: analysis of the impact of over-the-counter restrictions. Antimicrob Agents Chemother (2014) 1.72
Avoidable antibiotic exposure for uncomplicated skin and soft tissue infections in the ambulatory care setting. Am J Med (2013) 1.44
Trends and seasonal variation in outpatient antibiotic prescription rates in the United States, 2006 to 2010. Antimicrob Agents Chemother (2014) 1.11
Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae. Antimicrob Agents Chemother (2013) 1.11
Trends in antibiotic resistance in coagulase-negative staphylococci in the United States, 1999 to 2012. Antimicrob Agents Chemother (2013) 0.89
Germs are germs, and why not take a risk? Patients' expectations for prescribing antibiotics in an inner-city emergency department. Med Decis Making (2014) 0.86
Flurbiprofen microgranules for relief of sore throat: a randomised, double-blind trial. Br J Gen Pract (2013) 0.84
Antibiotic resistance in pediatric urology. Ther Adv Urol (2014) 0.81
Escherichia coli antibiotic resistance in emergency departments. Do local resistance rates matter? Eur J Clin Microbiol Infect Dis (2014) 0.81
Antibiotic use in the care home setting: a retrospective cohort study analysing routine data. BMC Geriatr (2015) 0.80
A cross sectional study on antibiotic resistance pattern of Salmonella typhi clinical isolates from Bangladesh. Asian Pac J Trop Biomed (2014) 0.80
Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008-2014. Int J Infect Dis (2016) 0.79
Antibiotic Use in Cold and Flu Season and Prescribing Quality: A Retrospective Cohort Study. Med Care (2015) 0.78
Limits to compensatory adaptation and the persistence of antibiotic resistance in pathogenic bacteria. Evol Med Public Health (2014) 0.78
Seasonality and Physician-related Factors Associated with Antibiotic Prescribing: A Cross-sectional Study in Isfahan, Iran. Int J Prev Med (2015) 0.77
Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a French hospital: a time series analysis. Eur J Clin Microbiol Infect Dis (2015) 0.77
Seasonal patterns of dengue fever and associated climate factors in 4 provinces in Vietnam from 1994 to 2013. BMC Infect Dis (2017) 0.75
Investigating the Extremes of Antibiotic Use with an Epidemiologic Framework. Antimicrob Agents Chemother (2016) 0.75
What should be considered if you decide to build your own mathematical model for predicting the development of bacterial resistance? Recommendations based on a systematic review of the literature. Front Microbiol (2015) 0.75
Influence of provider and urgent care density across different socioeconomic strata on outpatient antibiotic prescribing in the USA. J Antimicrob Chemother (2015) 0.75
Validating hospital antibiotic purchasing data as a metric of inpatient antibiotic use. J Antimicrob Chemother (2015) 0.75
Five-Year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analyses of Prevalence Data. PLoS One (2016) 0.75
Effect of meteorological factors and geographic location on methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in the US. PLoS One (2017) 0.75
Effectiveness of seasonal influenza vaccination in patients with diabetes: protocol for a nested case-control study. BMJ Open (2017) 0.75
Reversing resistance: different routes and common themes across pathogens. Proc Biol Sci (2017) 0.75
Adult and child malaria mortality in India: a nationally representative mortality survey. Lancet (2010) 7.89
Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis (2007) 6.75
Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis (2005) 5.58
Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis (2011) 3.54
Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis (2002) 3.46
Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J Med Res (2011) 2.36
Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis. Lancet (2010) 2.23
A systematic review of mathematical models of mosquito-borne pathogen transmission: 1970-2010. J R Soc Interface (2013) 2.14
Benefits of using multiple first-line therapies against malaria. Proc Natl Acad Sci U S A (2008) 2.13
Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Intern Med (2010) 2.11
Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis (2005) 2.05
Strategic interactions in multi-institutional epidemics of antibiotic resistance. Proc Natl Acad Sci U S A (2005) 1.92
Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? Infect Control Hosp Epidemiol (2011) 1.83
The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: a national observational study. Am J Epidemiol (2013) 1.67
Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations. Malar J (2009) 1.62
Optimal control of epidemics in metapopulations. J R Soc Interface (2009) 1.58
Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006. Emerg Infect Dis (2009) 1.56
Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis. Health Econ (2014) 1.54
Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infect Control Hosp Epidemiol (2011) 1.49
The Affordable Medicines Facility--malaria: killing it slowly. Lancet (2012) 1.47
Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patients. PLoS One (2011) 1.37
A sticky situation: the unexpected stability of malaria elimination. Philos Trans R Soc Lond B Biol Sci (2013) 1.32
A framework for global surveillance of antibiotic resistance. Drug Resist Updat (2011) 1.29
Synthesizing epidemiological and economic optima for control of immunizing infections. Proc Natl Acad Sci U S A (2011) 1.27
Trends in resistance to carbapenems and third-generation cephalosporins among clinical isolates of Klebsiella pneumoniae in the United States, 1999-2010. Infect Control Hosp Epidemiol (2013) 1.27
Clinically immune hosts as a refuge for drug-sensitive malaria parasites. Malar J (2008) 1.23
Recasting the theory of mosquito-borne pathogen transmission dynamics and control. Trans R Soc Trop Med Hyg (2014) 1.21
Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty. Malar J (2010) 1.20
Financing health improvements in India. Health Aff (Millwood) (2008) 1.14
Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam. BMC Public Health (2013) 1.11
Increasing resistance of acinetobacter species to imipenem in United States hospitals, 1999-2006. Infect Control Hosp Epidemiol (2010) 1.09
"One-size-fits-all"? Optimizing treatment duration for bacterial infections. PLoS One (2012) 1.05
Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India. Trop Med Int Health (2009) 1.01
Global investments in TB control: economic benefits. Health Aff (Millwood) (2009) 0.97
The unsurprising story of MDR-TB resistance in India. Tuberculosis (Edinb) (2012) 0.95
Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012. Emerg Infect Dis (2015) 0.94
Unit cost of medical services at different hospitals in India. PLoS One (2013) 0.93
Superinfection and the evolution of resistance to antimalarial drugs. Proc Biol Sci (2012) 0.92
The Socioeconomic and Institutional Determinants of Participation in India's Health Insurance Scheme for the Poor. PLoS One (2013) 0.92
Trends in antibiotic resistance in coagulase-negative staphylococci in the United States, 1999 to 2012. Antimicrob Agents Chemother (2013) 0.89
Should new antimalarial drugs be subsidized? J Health Econ (2010) 0.86
Cost-effectiveness of "golden mustard" for treating vitamin A deficiency in India. PLoS One (2010) 0.85
Economic issues and antibiotic resistance in the community. Ann Pharmacother (2002) 0.84
Costs of surgical procedures in Indian hospitals. BMJ Open (2013) 0.83
Multisite exploration of clinical decision making for antibiotic use by emergency medicine providers using quantitative and qualitative methods. Infect Control Hosp Epidemiol (2014) 0.83
Using oral vancomycin prescriptions as a proxy measure for Clostridium difficile infections: a spatial and time series analysis. Infect Control Hosp Epidemiol (2011) 0.83
Postgraduate education in nutrition in south Asia: a huge mismatch between investments and needs. BMC Med Educ (2014) 0.82
Is methicillin-susceptible Staphylococcus aureus (MSSA) sequence type 398 confined to Northern Manhattan? Rising prevalence of erythromycin- and clindamycin-resistant MSSA clinical isolates in the United States. Clin Infect Dis (2013) 0.81
Respiratory fluoroquinolone use and influenza. Infect Control Hosp Epidemiol (2011) 0.81
Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections. Antimicrob Resist Infect Control (2013) 0.80
Reinvesting in health post-2015. Lancet (2013) 0.79
East North Central region has the highest prevalence of vancomycin-resistant Enterococcus faecalis in the United States. Infect Control Hosp Epidemiol (2013) 0.79
Policy resistance undermines superspreader vaccination strategies for influenza. PLoS Comput Biol (2013) 0.78
Are physicians' prescribing decisions sensitive to drug prices? Evidence from a free-antibiotics program. Health Econ (2013) 0.77
The potential impact of age and season on methicillin-resistant Staphylococcus aureus prevalence. Future Microbiol (2013) 0.76
Resistance movement: Hospital administrators must join the fight against antibiotic overuse. Mod Healthc (2012) 0.75
Diversify or focus? Spending to combat infectious diseases when budgets are tight. J Health Econ (2012) 0.75